Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact Us
Customer Login
 


Headlines
 

04/21 13:49   Armenian foreign minister talks Karabakh settlement in Moscow
 
04/21 13:49   Lavrov: Ukrainian authorities disregard, flagrantly violate Geneva accords
 
04/21 13:48   It is impossible to isolate Russia - Lavrov (Part 3)
 
04/21 13:48   PUTIN SIGNS DECREE REHABILITATING CRIMEAN TATAR, ARMENIAN, GERMAN AND GREEK POPULATION OF CRIMEA
 
04/21 13:47   It is impossible to isolate Russia - Lavrov (Part 3)
 
04/21 13:46   It is impossible to isolate Russia - Lavrov (Part 3)
 
04/21 13:41   Number of Russian bank branches in Crimea to top 200 by end of April - Central Bank's Sukhov
 
04/21 13:40   Slovyansk shootout points to Kyiv's inability, reluctance to control extremists - Lavrov (Part 2)
 
04/21 13:39   Slovyansk shootout points to Kyiv's inability, reluctance to control extremists - Lavrov (Part 2)
 
04/21 13:39   Mechel Mining to cut board of directors to five members from nine
 




 

Interfax.com  |  Interfax news  |  FAS green-lights AFK Sistema bid to buy 100% of...


News headlines


November 12, 2012 15:08

FAS green-lights AFK Sistema bid to buy 100% of VeroPharm, but with terms (Part 2)

MOSCOW. Nov 12 (Interfax) - Russia's Federal Antimonopoly Service (FAS) has approved AFK Sistema's (RTS: AFKS) request for permission to buy 100% of the stock in pharmaceuticals company OJSC VeroPharm (RTS: VRPH), but has attached some terms, a FAS statement says.

The FAS established that VeroPharm has a dominating position on the market for medicines with MNN Gemifloksatsin, and its subsidiary LLC LENS-Pharm with MNN Poliadenilovaya Kislota + Poliuridilovaya Kislota.

The FAS takes the view that the conduct of this deal could lead to a limiting of access to the market for the sale of these medical preparations by independent counteragent VeroPharm and LENS-Pharm. In light of this, the FAS requires of Sistema and VeroPharm to ensure the fulfillment of all contracts for the delivery of all medicines existing on the date the deal is completed.

Before the deal is done, Sistema is to post on its official website the document regulating its commercial policy as regards VeroPharm medical preparations, and announce changes to commercial policy in letter form to the FAS within thirty days.

The parties are not to, from the date the deal is completed, effect any unfounded economic or technological reduction or halt of the production and supply of goods that are still in demand. They are also to announce to the FAS either of such circumstances in letter form within thirty days.

AFK Sistema and VeroPharm are to annually inform the FAS in letter form that they are meeting these conditions.

The parties to the deal are to announce its completion to the anti-monopoly agency within twenty days from the day the deal is wrapped up.

According to DSM Group data, VeroPharm is third in a rating of the largest Russian pharmaceutical companies. Company product is provided by three plants: in Belgorod, Voronezh, and Pokrov. VeroPharm specializes in the production of Rx medical goods, which account for about 70% of its sales revenues.

Pharmacy Chain 36.6 (RTS: APTK) owns 51.8% of the company.

Cf

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire

April 21, 2014
 
13:39
Slovyansk shootout points to Kyiv's inability, reluctance to control extremists - Lavrov (Part 2)
 
13:39
Mechel Mining to cut board of directors to five members from nine
 
13:37
No Eurobonds comment on April 21
 
13:36
 
13:33
Moscow accuses Kyiv of protracting constitutional reform (Part 2)
 
13:31
Lavrov: Moscow to foster interest of Russian businessmen in Mozambique
 
13:30
It is impossible to isolate Russia - Lavrov (Part 2)
 
13:30
It is impossible to isolate Russia - Lavrov (Part 2)
 
13:30
Keeping Maidan absolutely unacceptable - Lavrov (Part 2)
 
13:30
Keeping Maidan absolutely unacceptable - Lavrov (Part 2)
 
13:30
Probe ends into Georgian army operations in Aug 2008 - Defense Minister Alasania
 
13:30
It is impossible to isolate Russia - Lavrov (Part 2)
 
13:29
Keeping Maidan absolutely unacceptable - Lavrov (Part 2)
 
13:29
 
 more headlines 



Interviews
 

.
Spanish Ambassador to Russia Jose Ignacio Carbajal has given an interview to Interfax in which he speaks about the situation in Ukraine, the possible third phase of sanctions against Russia, and separatist trend that has lately come to shape in Europe.

more
.
.
Domenico Dispenza, president of the International Group of LNG Importers and former chief operating officer of Eni‘s gas and power division, speaks to Interfax about the group‘s new report on global LNG imports for 2013.

more
.
.
Interfax spoke to Dr. Leonhard Birnbaum, member of the board of management for markets and services at E.On, about the energy balance in Europe and gas’s place in it.

more

 
  
 ©   1991—2014   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100